Loading...
Please wait, while we are loading the content...
Similar Documents
19th Interventional Cardiology Workshop New Frontiers in Interventional Cardiology
| Content Provider | Semantic Scholar |
|---|---|
| Author | Wańha, Wojciech Roleder, Tomasz Mielczarek, Maksymilan Ładziński, Szymon Milewski, Marek P. Chmielecki, Michał Gilis-Malinowska, Natasza Ciećwierz, Dariusz Bachorski, Witold Kunik, Piotr Trznadel, Agata Genc, Alicja Januszek, Rafał Dziewierz, Artur Bartuś, Stanisław Gruchala, Marcin Smolka, Grzegorz Dudek, Dariusz Navarese, Eliano Pio Ochała, Andrzej Jaguszewski, Miłosz J. Wojakowski, Wojciech Gąsior, Paweł Gierlotka, Marek Szczurek-Katanski, Krzysztof Osuch, Marcin Hawranek, Michał Gąsior, Mariusz Polonski, Lech Ochijewicz, Dorota Tomaniak, Mariusz Kołtowski, Lukasz Rdzanek, Adam Pietrasik, Arkadiusz Jąkała, Jacek Legutko, Jacek Huczek, Zenon Filipiak, Krzysztof J. Opolski, Grzegorz Kochman, Janusz Roleder, Magda Jędrychowska, Magdalena Plens, Krzysztof Surdacki, Andrzej Lisiak, Magdalena Uchmanowicz, Izabella Paszek, Elżbieta Zajdel, Wojciech Żmudka, Krzysztof Kuźma, Łukasz Kożuch, Marcin Kralisz, Paweł Nowak, Konrad Pogorzelski, Szymon Róg-Makal, Magdalena Struniawski, Krzysztof Bachórzewska-Gajewska, Hanna Dobrzycki, Sławomir Kalińczuk, Łukasz Proczka, Michał Zieliński, Kamil Mintz, Gary S. Dębski, Mariusz A. Markiewicz, Michał Gwidon Sieradzki, Bartek Prȩgowski, Jerzy Dębski, Artur Łazarczyk, Hubert Ciszewski, Michal Chmielak, Zbigniew Dzielińska, Zofia Demkow, Marcin Witkowski, Adam Śpiewak, Mateusz Trochimiuk, Piotr Miłosz, Barbara Mazurkiewicz, Łukasz Trzciński, Adam Teresińska, Anna Marczak, Magdalena Wolny, Rafał Tyczyński, Paweł Proniewska, Klaudia Pregowska, Agnieszka Dam, P. Sytze Van Szczepanski, Janusz Henzel, Jan Bujak, Sebastian Moszura, Tomasz Kryczka, Karolina Kaczmarska-Dyrda, Edyta Broy-Jasik, Beata Kurowski, Andrzej |
| Copyright Year | 2018 |
| Abstract | s of original contributions 19th Interventional Cardiology Workshop New Frontiers in Interventional Cardiology December 6th, 2018, Krakow, Poland DOI: https://doi.org/10.5114/aic.2018.79881 Abstracts of original contributions from NFIC 2018s of original contributions from NFIC 2018 449 Advances in Interventional Cardiology 2018; 14, 4 (54) 1-P New-generation drug eluting stent vs. bare metal stent in saphenous vein graft – 1 year outcomes by a propensity score ascertainment (SVG Baltic Registry) Wojciech Wańha1,2, Tomasz Roleder1, Maksymilan Mielczarek3, Szymon Ładziński1, Marek Milewski1, Michał Chmielecki3, Natasza Gilis-Malinowska3, Dariusz Ciećwierz3, Witold Bachorski3, Piotr Kunik1, Agata Trznadel1, Alicja Genc3, Rafał Januszek4, Artur Dziewierz4, Stanisław Bartuś4, Marcin Gruchała3, Grzegorz Smolka1, Dariusz Dudek4, Eliano Pio Navarese2,5,6,7, Andrzej Ochała1, Miłosz Jaguszewski3, Wojciech Wojakowski1 1 Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland 2 SIRIO MEDICINE research network 3 First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland 4 Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland 5 Cardiovascular Institute, Nicolaus Copernicus University, Bydgoszcz, Poland 6 Interventional Cardiology and Cardiovascular Medicine Research, Mater Dei Hospital, Bari, Italy 7 Department of Cardiovascular Medicine, University of Alberta, Edmonton, Canada Background: Data regarding the efficacy of percutaneous coronary intervention (PCI) with new-designed drug eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare 1-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. Methods: We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year. This observation included 792 consecutive patients (mean age: 69 ±8.9 years), treated with either new-DES (n = 379, 47.9%) or BMS (n = 413, 52.1%). Results: In unmatched cohort patients treated with new-DES vs. BMS had lower MACCE (28.3% vs. 21.4%, HR = 0.69, 95% CI: 0.50–0.95, p = 0.025) as well as myocardial infarctions (MI) (12.1% vs. 6.3%; HR = 0.49, 95% CI: 0.30–0.82, p = 0.005) at 1 year. After propensity score matching similar, significant reduction in MACCE and MI was sustained in new-DES vs. BMS groups (HR = 0.66, 95% CI: 0.46–0.96, p = 0.030; and HR = 0.53, 95% CI: 0.31–0.92, p = 0.020, respectively). Conclusions: In patients undergoing PCI of SVG, the use of new-DES is associated with a reduced 1-year rate of MACCE and MI compared to BMS. |
| Starting Page | 447 |
| Ending Page | 458 |
| Page Count | 12 |
| File Format | PDF HTM / HTML |
| DOI | 10.5114/aic.2018.79881 |
| PubMed reference number | 30603041 |
| Journal | Medline |
| Volume Number | 14 |
| Alternate Webpage(s) | https://nfic.pl/images/files/Schedule_NFIC_2018_17.0.pdf |
| Alternate Webpage(s) | https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/a1/PWKI-14-34243.PMC6309839.pdf |
| Alternate Webpage(s) | https://nfic.pl/images/files/Schedule_NFIC_2018_21.0.pdf |
| Alternate Webpage(s) | http://nfic.pl/images/files/Schedule_NFIC_2018_8.0.pdf |
| Alternate Webpage(s) | https://doi.org/10.5114/aic.2018.79881 |
| Journal | Postepy w kardiologii interwencyjnej = Advances in interventional cardiology |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
